More than half of surveyed executives say that cost and integration remain obstacles to EDC adoption
Ottawa, ON (PRWEB) January 25, 2007
Contact research organizations (CRO) and pharmaceutical companies are looking for regulatory compliant (electronic data capture) EDC solutions that can be simply, quickly and cost-effectively deployed, while providing more flexible and user configurable functionality and adherence to data standardization, such as CDISC. TrialStat Corporation (http://www.trialstat.com), a clinical data management on demand company, commissioned an international survey of 100 CRO and pharmaceutical executives. The survey revealed that poor integration and high costs ranked as the number one and two obstacles respectively to adopting EDC solutions from third-parties. Eighty-five percent of those surveyed, meanwhile, reported that to implement and use EDC software typically takes four weeks or more.
“More than half of surveyed executives say that cost and integration remain obstacles to EDC adoption,” said Jonathan Barker, President and CEO, TrialStat. “These reasons point to a need to simplify EDC solutions to ensure that they can deliver a rapid and compelling return on investment. As a hosted solution, TrialStat provides an on demand EDC solution that can deploy studies, on average, in about half the time required by traditional EDC software while also offering significantly lower costs. This gives TrialStat customers a degree of agility and flexibility that is not available from other solutions.”
According to the AdvanStar Research Group’s survey, 38 percent of organizations cited improved data quality and reduced data entry errors as the main benefit of using EDC, while 33 percent claimed that EDC reduced the time required for data collection. Survey participants also listed a number of key features that they would like to see added to EDC solutions in the future. These include the following :
- Client configurable forms
- Integrated web and mobile data capture
- Harmonization with data exchange standards, such as CDISC
The AdvanStar Research Group completed a survey of Applied Clinical Trials and Pharmaceutical Executive readers in December 2006.
ClinicalAnalytics (CA) 4.0™, TrialStat’s on demand EDC solution, delivers speed, performance and a host of industry-leading capabilities to give customers the power and flexibility they need to get their clinical trials started quickly and cost effectively. CA 4.0 integrates the web and flexible data capture technologies, including image-based forms and handheld devices. It is the first EDC platform to allow all aspects of the study to be configured, deployed and managed through a browser-based interface, which enables customers to deploy studies in a matter of days. CA also supports international standards for data interchange, such as CDISC. TrialStat is a member of this consortium.
TrialStat Corporation is a privately held company that delivers clinical data management on demand by combining the company’s software as a service products with its full suite of data management services. CA 4.0 is a robust and scaleable clinical EDC on demand solution used by leading academic and contract research organizations. SRS 4.0™ automates systematic reviews using real-time collaboration and management tools to achieve transparent, auditable and reproducible results quickly and cost-effectively. For more information, please visit us at http://www.trialstat.com.
ClinicalAnalytics 4.0 and SRS 4.0 are registered trademarks of TrialStat Corporation.
For media inquiries, please contact:
613-741-9909 ext 155
# # #